Astrocyte Pharmaceuticals Banks $9.5M in Series B Round
Astrocyte Pharmaceuticals raised $9.5 million in Series B funding, per FinSMEs, adding capital to advance its astrocyte-targeting neurotherapeutics pipeline.
Topic
Neuroscience
Topic
Topic
Topic
Astrocyte Pharmaceuticals raised $9.5 million in Series B funding, per FinSMEs, adding capital to advance its astrocyte-targeting neurotherapeutics pipeline.